Labcorp Holdings Inc. (LH)
Healthcare
Diagnostics & Research
307.40 $
-0.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Labcorp Holdings Inc. (LH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 18,532 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16,886 | 16,725 | 16,531 | 16,712 | 18,613 | 18,379 | 17,604 | 18,060 | 18,262 | 18,393 | 19,087 | 18,532 | |
| 3,954 | 3,765 | 3,457 | 3,571 | 4,910 | 4,807 | 3,790 | 4,087 | 4,079 | 4,021 | 4,559 | 3,815 | |
| 728 | 537 | 99 | 265 | 1,517 | 1,519 | 369 | 647 | 598 | 532 | 981 | 142 | |
| 728 | 537 | 99 | 265 | 1,517 | 1,519 | 369 | 647 | 598 | 532 | 981 | 142 | |
| 2,065 | 2,099 | 2,204 | 2,246 | 2,225 | 2,097 | 2,275 | 2,277 | 2,265 | 2,261 | 2,451 | 2,505 | |
| 461 | 475 | 475 | 442 | 483 | 493 | 488 | 508 | 522 | 535 | 498 | 562 | |
| 2,821 | – | – | – | 3,050 | 3,045 | 3,091 | 3,134 | 3,113 | 3,082 | – | – | |
| 6,332 | 6,143 | 6,219 | 6,220 | 6,482 | 6,370 | 6,421 | 6,551 | 6,682 | 6,790 | 6,955 | 7,030 | |
| 3,276 | 3,342 | 3,394 | 3,332 | 3,541 | 3,489 | 3,487 | 3,494 | 3,571 | 3,596 | 3,636 | 3,678 | |
| 8,994 | 8,835 | 8,556 | 8,692 | 10,427 | 10,313 | 9,282 | 9,571 | 9,549 | 9,756 | 10,342 | 9,909 | |
| 2,901 | 3,225 | 3,942 | 4,065 | 3,412 | 3,330 | 2,065 | 2,717 | 2,629 | 2,824 | 2,641 | 2,125 | |
| 1,160 | 1,172 | 2,219 | 2,208 | 1,591 | 1,191 | 188 | 690 | 691 | 696 | 688 | 186 | |
| 691 | 828 | 696 | 761 | 661 | 876 | 718 | 793 | 669 | 841 | 696 | 689 | |
| 4,428 | 4,055 | 3,048 | 3,047 | 5,352 | 5,331 | 5,569 | 5,077 | 5,083 | 5,085 | 5,834 | – | |
| 7,873 | 7,875 | 7,960 | 8,006 | 8,170 | 8,052 | 8,307 | 8,473 | 8,697 | 8,620 | 8,729 | 8,607 | |
| 8,070 | 7,888 | 8,055 | 8,178 | 8,276 | 8,303 | 8,456 | 8,498 | 8,698 | 8,640 | 8,784 | 8,701 | |
| 87 | 85 | 85 | 84 | 84 | 84 | 84 | 84 | 84 | 83 | 83 | 82 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.